Variant report

Variant	rs10864906
Chromosome Location	chr2:113467144-113467145
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr2:113463027..113465747-chr2:113466375..113467999,2	K562	blood:
2	chr2:113465999..113468016-chr2:113469384..113470949,2	K562	blood:
3	chr2:113385104..113391547-chr2:113463938..113470179,6	K562	blood:
4	chr2:113443028..113446257-chr2:113466353..113468371,4	K562	blood:
5	chr2:113461776..113469381-chr2:113473397..113480932,10	K562	blood:

Variant related genes	Relation type
ENSG00000144130	Chromatin interaction

Extended variants
information (count: 9 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs2048876	0.89[EUR][1000 genomes]
rs4849108	0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv428724	chr2:113376894-113555421	Genic enhancers Strong transcription Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	56 gene(s)	inside rSNPs	diseases
2	nsv1010106	chr2:113394981-113556071	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
3	nsv526301	chr2:113451498-113495785	Strong transcription Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	9 gene(s)	inside rSNPs	diseases
4	esv3458160	chr2:113460280-113484749	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region	7 gene(s)	inside rSNPs	diseases
5	esv3458161	chr2:113460322-113484724	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	7 gene(s)	inside rSNPs	diseases
6	esv3458162	chr2:113460460-113484652	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	7 gene(s)	inside rSNPs	diseases
7	nsv441775	chr2:113462399-113478887	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:26 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:113458800-113469000	Enhancers	Primary hematopoietic stem cells short term culture	blood
2	chr2:113462000-113468800	Enhancers	Primary hematopoietic stem cells	blood
3	chr2:113462600-113469400	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr2:113462800-113469200	Enhancers	Primary B cells from peripheral blood	blood
5	chr2:113463000-113469000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
6	chr2:113463400-113467600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
7	chr2:113464200-113467200	Weak transcription	Brain Hippocampus Middle	brain
8	chr2:113464200-113486400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
9	chr2:113465200-113470600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr2:113465400-113467200	Weak transcription	Brain Substantia Nigra	brain
11	chr2:113465400-113468800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr2:113465400-113469000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr2:113465400-113470400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr2:113465400-113470600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr2:113465400-113470600	Weak transcription	HMEC	breast
16	chr2:113465400-113470600	Weak transcription	NHEK	skin
17	chr2:113465600-113468600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr2:113465600-113470400	Enhancers	K562	blood
19	chr2:113465800-113467600	Enhancers	Primary neutrophils fromperipheralblood	blood
20	chr2:113465800-113470600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr2:113466600-113467800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr2:113466600-113467800	Enhancers	Spleen	Spleen
23	chr2:113466600-113468000	Bivalent Enhancer	Fetal Muscle Leg	muscle
24	chr2:113466600-113468000	Enhancers	GM12878-XiMat	blood
25	chr2:113466800-113467200	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr2:113466800-113468200	Enhancers	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links